Bausch + Lomb (BLCO) Stock: Buy, Sell, or Hold?
$21.32
-0.05 (-0.23%)
▼
5d:
+3.5%
30d:
+34.85%
90d:
+25.56%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (22%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$16.46 – $19.89
Position: EXTENDED
Forward P/E & Valuation
17.9x
FAIR
vs 16.7x historical avg
Wall Street Target
$21.71
+1.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$19.52 / $21.40
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BLCO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When BLCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.83
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.11
11.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLCO is currently trading at $21.32, which is considered extended relative to its 30-day fair value range of $16.46 to $19.89. The stock's valuation (Forward PE: 17.9) is in line with its historical norms (16.7). At these levels, the market is pricing in 2.2% annual earnings growth.
Technical Outlook: Technically, BLCO is in a strong uptrend. The price is approaching resistance at $21.40. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BLCO scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLCO is in a strong uptrend. The price is approaching resistance at $21.40. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BLCO scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.46 -
$19.89
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
22.4%
Trading Range & Key Levels
30-Day Trading Range
$16.46 -
$19.89
Current vs Trading Range
EXTENDED
Support Level
$19.52
Resistance Level
$21.40
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+7.2% above its trading range)
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($21.71)
- BULLISH: Expecting earnings turnaround to 2.2% growth with 7.3% revenue growth
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
17.86
Wall Street Target
$21.71
(+1.8%)
Revenue Growth (YoY)
7.3%
Earnings Growth (YoY)
-88.6%
Profit Margin
-2.1%
Valuation Premium vs History
+2.2% premium
PE vs Historical
17.9 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$21.79
(+2%)
2-Year Target
$22.27
(+4%)
3-Year Target
$22.76
(+7%)
3-Yr Target (if PE normalizes)
(PE: 18→17)
PE COMPRESSION
$21.28
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 26.4%)
$47.86
(+125%)
Base:
(SPY PE: 17.9, Growth: 26.4%)
$43.03
(+102%)
Bear:
(PE: 15.2, Growth: 26.4%)
$36.58
(+72%)
Share BLCO Analysis
Share this live BLCO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BLCO)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bausch + Lomb introduces Orphia, an AI-powered digital health platform for pre-surgery cataract education.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
Data refreshes hourly during market hours. Next update: 4:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLCO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 40 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 50 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BLCO Research Pages
